|
US3051621A
(en)
*
|
1959-10-22 |
1962-08-28 |
Grove Lab Inc |
Gel composition, pressurized container with same, and method of preparation
|
|
US3050443A
(en)
*
|
1960-02-16 |
1962-08-21 |
James F Schuyler |
Headache remedy containing ammonia
|
|
NL262354A
(de)
*
|
1960-03-17 |
|
|
|
|
US3039928A
(en)
*
|
1960-03-17 |
1962-06-19 |
Abbott Lab |
Stable aqueous isoproteronol compositions
|
|
US3088874A
(en)
*
|
1960-05-23 |
1963-05-07 |
Union Carbide Corp |
Powder aerosol
|
|
US3282781A
(en)
*
|
1960-11-25 |
1966-11-01 |
Merck & Co Inc |
Inhalant compositions
|
|
BE632504A
(de)
*
|
1962-05-24 |
|
|
|
|
US3169095A
(en)
*
|
1962-10-30 |
1965-02-09 |
Rexall Drug Chemical |
Self-propelling powder-dispensing compositions
|
|
NL302251A
(de)
*
|
1963-01-28 |
1965-10-11 |
|
|
|
US3710782A
(en)
*
|
1969-10-01 |
1973-01-16 |
Hauser Res And Eng Co |
Method of treating human skin with a composition for electromedical applications
|
|
IL51314A
(en)
*
|
1976-01-30 |
1980-03-31 |
Fisons Ltd |
Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it
|
|
AU522792B2
(en)
*
|
1977-07-19 |
1982-06-24 |
Fisons Plc |
Pressure pack formulation
|
|
US4352789A
(en)
*
|
1980-03-17 |
1982-10-05 |
Minnesota Mining And Manufacturing Company |
Aerosol compositions containing finely divided solid materials
|
|
US4655231A
(en)
*
|
1984-01-09 |
1987-04-07 |
Advanced Tobacco Products, Inc. |
Snuff and preparation thereof
|
|
US4576949A
(en)
*
|
1984-05-07 |
1986-03-18 |
The Upjohn Company |
Use of 5,6,7,8-tetrahydroquinolines and 5,6-dihydropyrindines as leukotriene and lipoxygenase inhibitors and the novel 3-substituted compounds therein
|
|
EP0213108A3
(de)
*
|
1985-06-26 |
1987-07-15 |
Kurt Dr. Burghart |
Pharmazeutische Zubereitung mit einem Antihypotonikum als wirksames Mittel
|
|
JPH0645538B2
(ja)
*
|
1987-09-30 |
1994-06-15 |
日本化薬株式会社 |
ニトログリセリンスプレー剤
|
|
FR2625677A1
(fr)
*
|
1988-01-07 |
1989-07-13 |
Cosnier Alain |
Composition medicamenteuse destinee a etre administree sous forme d'aerosol
|
|
DE68915203T2
(de)
*
|
1988-03-22 |
1994-09-22 |
Fisons Plc, Ipswich, Suffolk |
Pharmazeutische Mischungen.
|
|
US5225183A
(en)
*
|
1988-12-06 |
1993-07-06 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
US5766573A
(en)
*
|
1988-12-06 |
1998-06-16 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
US5439670A
(en)
*
|
1989-11-28 |
1995-08-08 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
DE4003270A1
(de)
*
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
Neue treibgase und ihre verwendung in arzneimittelzubereitungen
|
|
US5118494A
(en)
*
|
1990-03-23 |
1992-06-02 |
Minnesota Mining And Manufacturing Company |
Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
|
|
US5175152A
(en)
*
|
1990-09-28 |
1992-12-29 |
Singh Nikhilesh N |
Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
|
|
MX9203481A
(es)
*
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
|
US5919435A
(en)
*
|
1990-11-09 |
1999-07-06 |
Glaxo Group Limited |
Aerosol formulation containing a particulate medicament
|
|
US5785952A
(en)
*
|
1990-11-09 |
1998-07-28 |
Glaxo Group Limited |
Aerosol medicament formulation having a surface coating of surfactant
|
|
CA2111003A1
(en)
|
1991-06-10 |
1992-12-23 |
Julianne Fassberg |
Non-chlorofluorocarbon aerosol formulations
|
|
US5234933A
(en)
*
|
1991-10-31 |
1993-08-10 |
Board Of Governors Of Wayne State University And Vanderbilt University |
Cyclic hydroxamic acids
|
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
|
NZ246046A
(en)
*
|
1991-12-12 |
1995-12-21 |
Glaxo Group Ltd |
Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
|
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
|
US5916540A
(en)
*
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
|
IL104068A
(en)
*
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
|
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
|
CA2421976C
(en)
*
|
1991-12-12 |
2004-04-20 |
Glaxo Group Limited |
Medicaments
|
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
|
EP0717987B1
(de)
*
|
1991-12-18 |
2001-08-29 |
Minnesota Mining And Manufacturing Company |
Aerosolzusammensetzungen für Arzneimittelsuspensionen
|
|
ES2129117T3
(es)
*
|
1992-12-09 |
1999-06-01 |
Boehringer Ingelheim Pharma |
Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
|
|
DK0632008T3
(da)
*
|
1993-06-01 |
1998-09-23 |
Ono Pharmaceutical Co |
Pentansyrederivater
|
|
EP0640609A1
(de)
*
|
1993-08-24 |
1995-03-01 |
Ono Pharmaceutical Co., Ltd. |
Kondensierte Phenolderivate mit Hemmwirkung auf TXA2 Synthetase und 5-Lipoxygenase, und zum Abfangen von Säuerstoffverbindungen
|
|
DK0656349T3
(da)
*
|
1993-12-03 |
1998-06-02 |
Ono Pharmaceutical Co |
Amidinophenolderivater med inhiberende virkning på phospholipase A2
|
|
DK0735884T3
(da)
*
|
1993-12-20 |
2000-10-09 |
Minnesota Mining & Mfg |
Flunisolid-aerosolformuleringer
|
|
EP0703216B1
(de)
|
1994-09-20 |
1999-04-07 |
Ono Pharmaceutical Co., Ltd. |
Amidinophenol-Derivate als Protease-hemmende Verbindungen
|
|
US5679287A
(en)
*
|
1995-04-28 |
1997-10-21 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
|
US5840213A
(en)
*
|
1995-04-28 |
1998-11-24 |
Great Lakes Chemical Corporation |
Uses of heptafluoropropane
|
|
KR980009238A
(ko)
|
1995-07-28 |
1998-04-30 |
우에노 도시오 |
설포닐아미노산 유도체
|
|
DK0757984T3
(da)
*
|
1995-08-08 |
2003-03-03 |
Ono Pharmaceutical Co |
Hydroxamsyrederivater, der kan anvendes til inhibering af gelatinase
|
|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
US5861268A
(en)
*
|
1996-05-23 |
1999-01-19 |
Biomide Investment Limited Partnership |
Method for induction of tumor cell apoptosis with chemical inhibitors targeted to 12-lipoxygenase
|
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
|
GB9616237D0
(en)
*
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
|
US6461591B1
(en)
|
1997-02-05 |
2002-10-08 |
Jago Research Ag |
Medical aerosol formulations
|
|
US5891419A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe flunisolide aerosol formulations for oral inhalation
|
|
US5891420A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
|
|
US6129905A
(en)
*
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
|
US7153866B1
(en)
*
|
1997-05-27 |
2006-12-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia
|
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
|
JPH11187882A
(ja)
|
1997-12-26 |
1999-07-13 |
Ono Pharmaceut Co Ltd |
新規なポリペプチド、その製造方法、そのポリペプチドをコードするｃＤＮＡ、そのｃＤＮＡからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのペプチドまたは抗体を含有する薬学的組成物
|
|
DE59911149D1
(de)
|
1998-07-24 |
2004-12-30 |
Jago Res Ag Muttenz |
Medizinische aerosolformulierungen
|
|
JP4672143B2
(ja)
|
1998-08-04 |
2011-04-20 |
ヤゴテック アーゲー |
医薬用エーロゾル製剤
|
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
|
US6136294C1
(en)
*
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
|
CN101921220B
(zh)
|
2001-07-23 |
2013-05-22 |
小野药品工业株式会社 |
治疗与骨质损失有关的疾病的含有ep4激动剂作为活性成分的药物组合物
|
|
DE60336890D1
(de)
|
2002-02-19 |
2011-06-09 |
Ono Pharmaceutical Co |
Kondensierte pyridazinderivat-verbindungen und die verbindungen als wirkstoff enthaltende arzneimittel
|
|
US7582284B2
(en)
*
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
|
EP1534235B1
(de)
|
2002-06-25 |
2016-07-27 |
Acrux DDS Pty Ltd |
Kontrolle der transdermalen abgaberate mit amorphen pharmazeutischen zusammensetzungen
|
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
|
EP1522314B1
(de)
|
2002-06-26 |
2014-03-05 |
Ono Pharmaceutical Co., Ltd. |
Arzneimittel für durch vaskuläre kontraktion oder dilatation hervorgerufene erkrankungen
|
|
US7595048B2
(en)
|
2002-07-03 |
2009-09-29 |
Ono Pharmaceutical Co., Ltd. |
Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1
|
|
TW200408393A
(en)
|
2002-10-03 |
2004-06-01 |
Ono Pharmaceutical Co |
Antagonist of lysophosphatidine acid receptor
|
|
EP1563845A4
(de)
*
|
2002-10-10 |
2008-02-20 |
Univ Kyoto |
Heilmittel f r allergieerkrankungen
|
|
EP1563846B1
(de)
|
2002-10-10 |
2012-08-29 |
Ono Pharmaceutical Co., Ltd. |
Endogene reparaturfaktoren herstellende promoter
|
|
WO2004072286A1
(ja)
|
2003-01-23 |
2004-08-26 |
Ono Pharmaceutical Co., Ltd. |
ヒトｐｄ−１に対し特異性を有する物質
|
|
NZ542304A
(en)
|
2003-03-14 |
2009-07-31 |
Ono Pharmaceutical Co |
Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
|
|
US7498323B2
(en)
|
2003-04-18 |
2009-03-03 |
Ono Pharmaceuticals Co., Ltd. |
Spiro-piperidine compounds and medicinal use thereof
|
|
AU2004240629B2
(en)
*
|
2003-05-16 |
2010-02-25 |
Arriva Pharmaceuticals, Inc. |
Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors
|
|
WO2006031210A1
(en)
|
2003-05-29 |
2006-03-23 |
Board Of Regents, The University Of Texas Systems |
Jabi as a prognostic marker and a therapeutic target for human cancer
|
|
US20070270489A1
(en)
|
2003-07-25 |
2007-11-22 |
Ono Pharmaceutical Co., Ltd. |
Remedy for Cartilage-Related Diseases
|
|
KR101186386B1
(ko)
|
2003-08-29 |
2012-09-26 |
오노 야꾸힝 고교 가부시키가이샤 |
Ｓ１ｐ 수용체 결합능을 갖는 화합물 및 그 의약 용도
|
|
NZ545666A
(en)
|
2003-09-01 |
2009-11-27 |
Ono Pharmaceutical Co |
Condensed ring compound and use thereof
|
|
JP2007505136A
(ja)
*
|
2003-09-10 |
2007-03-08 |
マツプ・フアーマシユーテイカルズ・インコーポレーテツド |
ジヒドロエルゴタミンを肺吸入により体循環に送達するためのエアゾール製剤
|
|
SG147453A1
(en)
*
|
2003-10-20 |
2008-11-28 |
Schering Corp |
Pharmaceutical aerosol compositions
|
|
WO2005063704A1
(ja)
|
2003-12-25 |
2005-07-14 |
Ono Pharmaceutical Co., Ltd. |
アゼチジン環化合物およびその医薬
|
|
WO2006004646A1
(en)
*
|
2004-06-28 |
2006-01-12 |
Nektar Therapeutics |
Aerosol formulation comprising nicotine salt
|
|
WO2006043615A1
(ja)
|
2004-10-21 |
2006-04-27 |
Ono Pharmaceutical Co., Ltd. |
免疫抑制受容体の用途
|
|
EP1814538B1
(de)
*
|
2004-11-24 |
2009-09-23 |
Alcon, Inc. |
Verfahren zur Verabreichung eines Nasensprays
|
|
US8563581B2
(en)
|
2005-02-02 |
2013-10-22 |
Mitos Pharmaceuticals, Inc. |
Nitroxides for use in treating predisposed or at risk patients
|
|
US8546423B2
(en)
*
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
RS55114B1
(sr)
|
2005-05-18 |
2016-12-30 |
Raptor Pharmaceuticals Inc |
Aerosolizovani fluorohinoloni i njihove upotrebe
|
|
EP2656860B1
(de)
|
2005-06-17 |
2021-05-05 |
Wisconsin Alumni Research Foundation |
Topische gefässverengende Zubereitungen und Zellschutzverfahren für Chemotherapie und Strahlentherapie bei Krebs
|
|
PL1942108T3
(pl)
|
2005-10-28 |
2014-03-31 |
Ono Pharmaceutical Co |
Związek zawierający grupę zasadową i jego zastosowanie
|
|
WO2007069565A1
(ja)
|
2005-12-12 |
2007-06-21 |
Ono Pharmaceutical Co., Ltd. |
二環式複素環化合物
|
|
EP1961754A4
(de)
|
2005-12-15 |
2009-11-11 |
Ono Pharmaceutical Co |
Bicyclische heterocyclische verbindung
|
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
|
ES2538082T3
(es)
*
|
2007-02-11 |
2015-06-17 |
Map Pharmaceuticals Inc |
Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
|
|
TW200902019A
(en)
|
2007-04-26 |
2009-01-16 |
Ono Pharmaceutical Co |
Dicyclic heterocyclic compound
|
|
DE102008007198A1
(de)
|
2008-02-01 |
2009-08-13 |
Infectopharm Arzneimittel Und Consilium Gmbh |
Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
|
|
HRP20201150T8
(hr)
|
2008-10-07 |
2021-06-25 |
Horizon Orphan Llc |
Inhalacija levofloksacina za smanjenje upale pluća
|
|
WO2010042553A1
(en)
|
2008-10-07 |
2010-04-15 |
Mpex Pharmaceuticals, Inc. |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
|
TWI469965B
(zh)
|
2008-12-22 |
2015-01-21 |
Ono Pharmaceutical Co |
乙炔基吲哚化合物
|
|
EP2444401B1
(de)
|
2009-06-17 |
2014-09-03 |
ONO Pharmaceutical Co., Ltd. |
Neue imidazopyridinverbindung
|
|
US20110171141A1
(en)
*
|
2009-06-26 |
2011-07-14 |
Kellerman Donald J |
Administration of dihydroergotamine mesylate particles using a metered dose inhaler
|
|
WO2011029059A1
(en)
|
2009-09-04 |
2011-03-10 |
Mpex Pharmaceuticals, Inc. |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
|
WO2011066537A1
(en)
|
2009-11-30 |
2011-06-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide therapy for the treatment of von hippel - lindau disease (vhl) and renal clear cell carcinoma (rcc)
|
|
MY162757A
(en)
|
2010-06-21 |
2017-07-14 |
Ono Pharmaceutical Co |
New Crystalline Forms of 4,4’-[4-Fluoro-7-({4-[4-(3-Fluoro-2-Methylphenyl) Butoxy] Phenyl}Ethynyl)-2-Methyl-1H-Indole-1, 3-Diyl] Dibutanoic Acid
|
|
ES2529129T3
(es)
|
2010-12-02 |
2015-02-17 |
Ono Pharmaceutical Co., Ltd. |
Nuevo compuesto y uso médico del mismo
|
|
EP2670242B1
(de)
|
2011-01-31 |
2022-03-16 |
Avalyn Pharma Inc. |
Aerosolförmige pirfenidon- und pyridonanalogverbindungen und verwendungen davon
|
|
US9353113B2
(en)
|
2011-03-18 |
2016-05-31 |
Ono Pharmaceutical Co., Ltd. |
Tetrahydrocarboline derivative
|
|
EP2842955B1
(de)
|
2012-04-26 |
2016-10-05 |
ONO Pharmaceutical Co., Ltd. |
Trk-hemmende verbindung
|
|
TWI567068B
(zh)
|
2013-02-19 |
2017-01-21 |
小野藥品工業股份有限公司 |
Ｔｒｋ抑制化合物
|
|
EP3027026B1
(de)
|
2013-07-31 |
2024-11-13 |
Avalyn Pharma Inc. |
Aerosoltyrosinkinasehemmer-verbindungen und verwendungen davon
|
|
US9770443B2
(en)
|
2014-01-10 |
2017-09-26 |
Genoa Pharmaceuticals, Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
|
WO2015115673A1
(en)
|
2014-01-31 |
2015-08-06 |
Ono Pharmaceutical Co., Ltd. |
Fused imidazole compounds
|
|
US12383608B2
(en)
|
2016-11-30 |
2025-08-12 |
Sumitomo Pharma Co., Ltd. |
WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides
|
|
WO2018181648A1
(ja)
|
2017-03-30 |
2018-10-04 |
大日本住友製薬株式会社 |
Ｗｔ１癌抗原ペプチドおよびこれを含むペプチドコンジュゲート体
|
|
EP3679932A1
(de)
|
2017-09-06 |
2020-07-15 |
ONO Pharmaceutical Co., Ltd. |
Verfahren zur behandlung von krebs durch kombination aus einem trk-inhibitor und kinase-inhibitor
|
|
JP7388635B2
(ja)
|
2018-05-31 |
2023-11-29 |
小野薬品工業株式会社 |
免疫チェックポイント阻害薬の有効性判定バイオマーカー
|
|
TWI855000B
(zh)
|
2018-10-11 |
2024-09-11 |
日商小野藥品工業股份有限公司 |
Ｓｔｉｎｇ促效化合物
|
|
MX2022001434A
(es)
|
2019-08-05 |
2022-02-22 |
Ono Pharmaceutical Co |
Biomarcadores para determinar la eficacia de los inhibidores de puntos de control inmunitarios.
|
|
WO2021107125A1
(ja)
|
2019-11-29 |
2021-06-03 |
小野薬品工業株式会社 |
リゾホスファチジン酸受容体作動活性を有する化合物およびその医薬用途
|
|
CA3167312A1
(en)
|
2020-02-07 |
2021-08-12 |
Stephen J. Lewis |
Compositions and methods for attenuating opioid induced cardio and/or respiratory depression
|
|
WO2021205631A1
(ja)
|
2020-04-10 |
2021-10-14 |
小野薬品工業株式会社 |
Ｓｔｉｎｇ作動化合物
|
|
JP7153287B2
(ja)
|
2020-05-12 |
2022-10-14 |
住友ファーマ株式会社 |
癌を処置するための医薬組成物
|
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
|
WO2022251679A1
(en)
|
2021-05-27 |
2022-12-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide radicals for use as antiviral treatment for coronavirus infection
|
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|